Related references
Note: Only part of the references are listed.Erythrocyte purinergic signaling components underlie hypoxia adaptation
Kaiqi Sun et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent
Anren Song et al.
NATURE COMMUNICATIONS (2017)
Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension
Allan K. N. Alencar et al.
FRONTIERS IN PHARMACOLOGY (2017)
Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension
Krishna C. Penumatsa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
Jerome Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis
Scott D. Collum et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase
Chen Liu et al.
AMERICAN JOURNAL OF HYPERTENSION (2017)
Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives
Scott D. Collum et al.
CANADIAN RESPIRATORY JOURNAL (2017)
Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension
Ning-Yuan Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension
Luis J. Garcia-Morales et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Extracellular Adenosine Production by ecto-5′-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis
Florian Wirsdoerfer et al.
CANCER RESEARCH (2016)
Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments
James R. Klinger
CARDIOLOGY CLINICS (2016)
Purinergic signaling in scarring
Davide Ferrari et al.
FASEB JOURNAL (2016)
Medicinal chemistry of adenosine, P2Y and P2X receptors
Kenneth A. Jacobson et al.
NEUROPHARMACOLOGY (2016)
Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs
Hartmut Grasemann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Leptin signalling system as a target for pulmonary arterial hypertension therapy
Alice Huertas et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension
Harry Karmouty-Quintana et al.
FASEB JOURNAL (2015)
Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia
Chen Liu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Elevated Transglutaminase 2 Activity Is Associated with Hypoxia-Induced Experimental Pulmonary Hypertension in Mice
Thomas R. DiRaimondo et al.
ACS CHEMICAL BIOLOGY (2014)
Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation
Krishna C. Penumatsa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules
Keith C. Olsen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Increased Pericyte Coverage Mediated by-Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle-Like Cells in Pulmonary Hypertension
Nicolas Ricard et al.
CIRCULATION (2014)
Tissue Transglutaminase Contributes to the Pathogenesis of Preeclampsia and Stabilizes Placental Angiotensin Receptor Type 1 by Ubiquitination-Preventing Isopeptide Modification
Chen Liu et al.
HYPERTENSION (2014)
TRANSGLUTAMINASE REGULATION OF CELL FUNCTION
Richard L. Eckert et al.
PHYSIOLOGICAL REVIEWS (2014)
Adenosine promotes vascular barrier function in hyperoxic lung injury
Jonathan Davies et al.
PHYSIOLOGICAL REPORTS (2014)
Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats
S. Schroll et al.
ACTA PHYSIOLOGICA (2013)
Adenosine A2B Receptor and Hyaluronan Modulate Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
Harry Karmouty-Quintana et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Adenosine signaling during acute and chronic disease states
Harry Karmouty-Quintana et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver
Michael A. Zimmerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation
Yihua Bei et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)
Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Keng Jin Lee et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Transglutaminase 2: A molecular Swiss army knife
Soner Gundemir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Idliopathic Pulmonary Fibrosis: Phenotypes and Comorbidities
Charlene D. Fell
CLINICS IN CHEST MEDICINE (2012)
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Eoin P. Judge et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease
Harry Karmouty-Quintana et al.
FASEB JOURNAL (2012)
World Health Organization Group III pulmonary hypertension
Hooman D. Poor et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2012)
WHO Group 1 pulmonary arterial hypertension: Current and investigative therapies
Corey E. Ventetuolo et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2012)
Pulmonary Hypertension in Parenchymal Lung Disease
Rosechelle M. Ruggiero et al.
HEART FAILURE CLINICS (2012)
GS-6201, a Selective Blocker of the A2B Adenosine Receptor, Attenuates Cardiac Remodeling after Acute Myocardial Infarction in the Mouse
Stefano Toldo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Transglutaminase 2 and Its Role in Pulmonary Fibrosis
Keith C. Olsen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
A Novel Murine Model of Severe Pulmonary Arterial Hypertension
Loredana Ciuclan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis A Tale of Angiogenesis, Apoptosis, and Growth Factors
Laszlo Farkas et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Lung Extracellular Superoxide Dismutase Overexpression Lessens Bleomycin-Induced Pulmonary Hypertension and Vascular Remodeling
Zachary Van Rheen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice
Keunhee Oh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Interleukin-6 Contributes to Inflammation and Remodeling in a Model of Adenosine Mediated Lung Injury
Mesias Pedroza et al.
PLOS ONE (2011)
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis: A Review
Georgia Pitsiou et al.
RESPIRATION (2011)
Basic Science of Pulmonary Arterial Hypertension for Clinicians New Concepts and Experimental Therapies
Stephen L. Archer et al.
CIRCULATION (2010)
SP1-Dependent Induction of CD39 Facilitates Hepatic Ischemic Preconditioning
Melanie L. Hart et al.
JOURNAL OF IMMUNOLOGY (2010)
Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
Yang Zhou et al.
PLOS ONE (2010)
Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan
Stephan Schroll et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2010)
Role of Extracellular Adenosine in Acute Lung Injury
Tobias Eckle et al.
PHYSIOLOGY (2009)
Adenosine signaling and the regulation of chronic lung disease
Yang Zhou et al.
PHARMACOLOGY & THERAPEUTICS (2009)
PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation
Anna R. Hemnes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Standardized quantification of pulmonary fibrosis in histological samples
Ralf-Harto Huebner et al.
BIOTECHNIQUES (2008)
Pulmonary hypertension in interstitial lung disease
J. Behr et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Adenosine, an endogenous distress signal, modulates tissue damage and repair
B. B. Fredholm
CELL DEATH AND DIFFERENTIATION (2007)
Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury
Tobias Eckle et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26
Annemie Van Linden et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury
Chun-Xiao Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury
Jonathan B. Volmer et al.
JOURNAL OF IMMUNOLOGY (2006)
Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations
JL Chunn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
HK Eltzschig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats
C Guignabert et al.
CIRCULATION (2005)
Altered growth responses of muscle cells from patients pulmonary artery smooth with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins
NW Morrell et al.
CIRCULATION (2001)
Share Paper
